New drug EP395 passes first safety check in healthy volunteers
NCT ID NCT04819854
First seen Apr 29, 2026 · Last updated May 18, 2026 · Updated 2 times
Summary
This early-stage study tested the safety of a new drug called EP395 in 78 healthy adults aged 18 to 65. Participants took single or multiple doses of EP395 in capsule form. The goal was to find a safe dose range for future research. The study focused on side effects, heart activity, temperature, blood pressure, pulse, and hearing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT ALL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Medicines Evaluation Unit (MEU) Ltd.
Manchester, M23 9QZ, United Kingdom
Conditions
Explore the condition pages connected to this study.